Lenvatinib and Pembrolizumab as save and effective combination treatment in 8 patients with metastasized anaplastic (ATC) and poorly differentiated thyroid carcinomas (PDTC)

被引：0
|
作者：
Dierks, C. [1 ]
Miething, C. [1 ]
von Bubnoff, N. [1 ]
Duyster, J. [1 ]
Thomusch, O. [2 ]
机构：
[1] Uniklin Freiburg, Hamatol Onkol, Freiburg, Germany
[2] Uniklin Freiburg, Allgemeinchirurg, Freiburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P936
引用
收藏
页码：306 / 306
页数：1
相关论文
共 14 条
  • [1] Lenvatinib and pembrolizumab as save and effective combination treatment in 8 patients with metastasized anaplastic (ATC) or poorly differentiated thyroid carcinoma (PDTC)
    Dierks, C.
    Miething, C.
    Thomusch, O.
    von Bubnoff, N.
    Duyster, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
    Dierks, Christine
    Seufert, Jochen
    Aumann, Konrad
    Ruf, Juri
    Klein, Claudius
    Kiefer, Selina
    Rassner, Michael
    Boerries, Melanie
    Zielke, Andreas
    la Rosee, Paul
    Meyer, Philipp Tobias
    Kroiss, Matthias
    Weissenberger, Christian
    Schumacher, Tilmann
    Metzger, Patrick
    Weiss, Harald
    Smaxwil, Constantin
    Laubner, Katharina
    Duyster, Justus
    von Bubnoff, Nikolas
    Miething, Cornelius
    Thomusch, Oliver
    THYROID, 2021, 31 (07) : 1076 - 1085
  • [3] Evaluation of real-word efficacy in Lenvatinib and Pembrolizumab treated poorly (PDTC) and anaplastic (ATC) thyroid cancer patients
    Brandenburg, Tim
    Machlah, Yara Maria
    Theurer, Sarah
    Dralle, Henning
    Weber, Manuel
    Weber, Frank
    Lahner, Harald
    Fuehrer-Sakel, Dagmar
    INNERE MEDIZIN, 2024, 65 : S92 - S93
  • [4] Phase II ATLEP trial: Final results for lenvatinib/pembrolizumab in metastasized anaplastic and poorly differentiated thyroid carcinoma
    Dierks, C.
    Ruf, J.
    Seufert, J.
    Kreissl, M.
    Klein, C.
    Spitzweg, C.
    Kroiss, M.
    Thomusch, O.
    Lorenz, K.
    Zielke, A.
    Miething, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1295 - S1295
  • [5] Final Data from the ATLEP Phase II Study: Lenvatinib and Pembrolizumab in anaplastic and poorly differentiated Thyroid Carcinoma
    Dierks, C.
    Ruf, J.
    Klein, C.
    Seufert, J.
    Kroiss, M.
    La Rosee, P.
    Spitzweg, C.
    Kreissl, M.
    Binder, M.
    Von Bubnoff, N.
    Miething, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 154 - 154
  • [6] Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report
    Luongo, Cristina
    Porcelli, Tommaso
    Sessa, Francesca
    De Stefano, Maria Angela
    Scavuzzo, Francesco
    Damiano, Vincenzo
    Klain, Michele
    Bellevicine, Claudio
    Matano, Elide
    Troncone, Giancarlo
    Schlumberger, Martin
    Salvatore, Domenico
    CURRENT ONCOLOGY, 2021, 28 (06) : 5401 - 5407
  • [7] Camrelizumab plus apatinib mesylate in patients with recurrent or metastatic poorly differentiated thyroid carcinoma (PDTC) /anaplastic thyroid carcinoma (ATC): A prospective, open-label, phase II study
    Cao, J.
    Ji, Q.
    Fang, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S1121 - S1121
  • [8] Anaplastic and Poorly Differentiated Thyroid Carcinoma: Therapeutic Strategies and Treatment Outcome of 52 Consecutive Patients
    Siironen, P.
    Hagstrom, J.
    Maenpaa, H. O.
    Louhimo, J.
    Heikkila, A.
    Heiskanen, I.
    Arola, J.
    Haglund, C.
    ONCOLOGY, 2010, 79 (5-6) : 400 - 408
  • [9] The lenvatinib/pembrolizumab combination induces long lasting and complete responses in patients with metastatic anaplastic or poorly differentiated thyroid carcinoma: Results from a retrospective study and first results from the prospective phase II ATLEP trial
    Dierks, C.
    Seufert, J.
    Ruf, J.
    Duyster, J.
    Thomusch, O.
    Miething, C.
    Zielke, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1085 - S1085
  • [10] Effective Lenvatinib Treatment Complicated with Secondary Tracheocutaneous Fistula in Patients with Advanced Anaplastic Thyroid Carcinoma
    Wu, Wen-Chi
    Lai, Jiun-, I
    Chen, Jui-Yu
    Liu, Chun-Yu
    REPORTS, 2019, 2 (03)
12